0001813229-22-000002.txt : 20220311 0001813229-22-000002.hdr.sgml : 20220311 20220311130819 ACCESSION NUMBER: 0001813229-22-000002 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20220311 DATE AS OF CHANGE: 20220311 EFFECTIVENESS DATE: 20220311 FILER: COMPANY DATA: COMPANY CONFORMED NAME: BCD Bioscience, Inc. CENTRAL INDEX KEY: 0001813229 IRS NUMBER: 832990500 STATE OF INCORPORATION: WA FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-436931 FILM NUMBER: 22732211 BUSINESS ADDRESS: STREET 1: 231 G STREET STREET 2: SUITE 24 CITY: DAVIS STATE: CA ZIP: 95616 BUSINESS PHONE: (530) 400-8155 MAIL ADDRESS: STREET 1: 231 G STREET STREET 2: SUITE 24 CITY: DAVIS STATE: CA ZIP: 95616 D 1 primary_doc.xml X0708 D LIVE 0001813229 BCD Bioscience, Inc. 231 G STREET SUITE 24 DAVIS CA CALIFORNIA 95616 (530) 400-8155 WASHINGTON Calyxo Biosystems, Inc. None Corporation true 2019 Steven Watkins 231 G Street Suite 24 Davis CA CALIFORNIA 95616 Executive Officer Director Promoter Carlito Lebrilla 231 G Street Suite 24 Davis CA CALIFORNIA 95616 Director Promoter Biotechnology Decline to Disclose 06b false 2022-02-24 false true false 0 13000010 11598050 1401960 false 12 0 0 0 false BCD Bioscience, Inc. Steven Watkins Steven Watkins, Phd Chief Executive Officer 2022-03-11